Loading…

Thyroid-Stimulating Hormone Receptor Autoimmunity and Local Factors in Multiple Risk Factors Are Mainly Involved in the Occurrence of Pretibial Myxedema

Pretibial myxedema (PTM) is a local mucinous dermopathy associated with thyroid diseases. Since the etiology of PTM is unclear, the aim of this study is to identify the risk factors for PTM and their etiological roles in PTM occurrence. A large-scale case-control study (n = 1,200) was performed to i...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine research 2020-11, Vol.12 (11), p.711-723
Main Authors: Lan, Changgui, Hu, Liping, Liao, Chengqi, Shi, Yuhong, Wang, Yi, Cheng, Shuanghua, Huang, Wei
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c257t-3617882830c12ec30a250984f84f6a409114e6afeca78b8755be782a4c9fec383
cites
container_end_page 723
container_issue 11
container_start_page 711
container_title Journal of clinical medicine research
container_volume 12
creator Lan, Changgui
Hu, Liping
Liao, Chengqi
Shi, Yuhong
Wang, Yi
Cheng, Shuanghua
Huang, Wei
description Pretibial myxedema (PTM) is a local mucinous dermopathy associated with thyroid diseases. Since the etiology of PTM is unclear, the aim of this study is to identify the risk factors for PTM and their etiological roles in PTM occurrence. A large-scale case-control study (n = 1,200) was performed to identify risk factors for PTM by calculating odds ratio (OR) values and 95% confidential intervals. The PTM group entered a glucocorticoid treatment trial. Patients with complete response were followed up to the first relapse in a cohort study. The relative risk (RR) values of the main risk factors were calculated for PTM relapse to test their etiological roles. Among the 19 factors, six risk factors were identified: thyroid-stimulating hormone (TSH) receptor antibody (TRAb) (OR 42.93), autoimmune thyroid disease (AITD) or AITD history (OR 10.30), local trauma (OR 6.55), venous stasis posture (OR 6.16), cigarette smoking (OR 4.48), and age (OR 1.05). Serum TRAb levels were positively correlated with the severity of PTM. Of note, 371/400 patients received glucocorticoid treatment, and 330 achieved complete response. The serum TRAb levels after treatment decreased dramatically compared with those before treatment. After stopping glucocorticoid treatment, serum TRAb levels increased significantly when PTM relapsed (P < 0.001). In 165 relapse cases, an increase in serum TRAb levels occurred first, followed by persistent venous stasis posture or local trauma and finally PTM. The RR of elevated serum TRAb levels was 6.73 in PTM relapse cases. In the elevated serum TRAb level group, the RRs of local trauma, venous stasis posture, and local trauma plus venous stasis posture were 8.81, 6.5, and 8.84, respectively, for PTM relapse cases. TSHR autoimmunity and local factors in the six identified risk factors are the main causes of PTM occurrence.
doi_str_mv 10.14740/jocmr4352
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7665869</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2463602991</sourcerecordid><originalsourceid>FETCH-LOGICAL-c257t-3617882830c12ec30a250984f84f6a409114e6afeca78b8755be782a4c9fec383</originalsourceid><addsrcrecordid>eNpVkd9qFDEUxoMotrS98QEklyKM5t_MZG6EpVhb2KXS1uuQzZzppmaSNckszpv4uEZbh3oInEO-3_kS-BB6Q8kHKlpBPj4EM0bBa_YCHdOOyooTSl8uM-FH6CylB1KKcyqJfI2OOGdM8JYfo193uzkG21e32Y6T09n6e3wZ4hg84BswsM8h4tWUgx3Hyds8Y-17vA5GO3yhTVETth5vJpft3pUdm74vwioC3mjr3Yyv_CG4A_R_4LwDfG3MFCN4AzgM-GuEbLe2eG7mn9DDqE_Rq0G7BGdP_QR9u_h8d35Zra-_XJ2v1pVhdZsr3tBWSiY5MZSB4USzmnRSDOU0WpCOUgGNHsDoVm5lW9dbaCXTwnTljkt-gj49-u6n7Qi9AZ-jdmof7ajjrIK26n_F2526DwfVNk0tm64YvHsyiOHHBCmr0SYDzmkPYUqKiYY3hHUdLej7R9TEkFKEYXmGEvU3TbWkWeC3zz-2oP-y478BWiOelA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2463602991</pqid></control><display><type>article</type><title>Thyroid-Stimulating Hormone Receptor Autoimmunity and Local Factors in Multiple Risk Factors Are Mainly Involved in the Occurrence of Pretibial Myxedema</title><source>PubMed Central</source><creator>Lan, Changgui ; Hu, Liping ; Liao, Chengqi ; Shi, Yuhong ; Wang, Yi ; Cheng, Shuanghua ; Huang, Wei</creator><creatorcontrib>Lan, Changgui ; Hu, Liping ; Liao, Chengqi ; Shi, Yuhong ; Wang, Yi ; Cheng, Shuanghua ; Huang, Wei</creatorcontrib><description>Pretibial myxedema (PTM) is a local mucinous dermopathy associated with thyroid diseases. Since the etiology of PTM is unclear, the aim of this study is to identify the risk factors for PTM and their etiological roles in PTM occurrence. A large-scale case-control study (n = 1,200) was performed to identify risk factors for PTM by calculating odds ratio (OR) values and 95% confidential intervals. The PTM group entered a glucocorticoid treatment trial. Patients with complete response were followed up to the first relapse in a cohort study. The relative risk (RR) values of the main risk factors were calculated for PTM relapse to test their etiological roles. Among the 19 factors, six risk factors were identified: thyroid-stimulating hormone (TSH) receptor antibody (TRAb) (OR 42.93), autoimmune thyroid disease (AITD) or AITD history (OR 10.30), local trauma (OR 6.55), venous stasis posture (OR 6.16), cigarette smoking (OR 4.48), and age (OR 1.05). Serum TRAb levels were positively correlated with the severity of PTM. Of note, 371/400 patients received glucocorticoid treatment, and 330 achieved complete response. The serum TRAb levels after treatment decreased dramatically compared with those before treatment. After stopping glucocorticoid treatment, serum TRAb levels increased significantly when PTM relapsed (P &lt; 0.001). In 165 relapse cases, an increase in serum TRAb levels occurred first, followed by persistent venous stasis posture or local trauma and finally PTM. The RR of elevated serum TRAb levels was 6.73 in PTM relapse cases. In the elevated serum TRAb level group, the RRs of local trauma, venous stasis posture, and local trauma plus venous stasis posture were 8.81, 6.5, and 8.84, respectively, for PTM relapse cases. TSHR autoimmunity and local factors in the six identified risk factors are the main causes of PTM occurrence.</description><identifier>ISSN: 1918-3003</identifier><identifier>EISSN: 1918-3011</identifier><identifier>DOI: 10.14740/jocmr4352</identifier><identifier>PMID: 33224373</identifier><language>eng</language><publisher>Canada: Elmer Press</publisher><subject>Original</subject><ispartof>Journal of clinical medicine research, 2020-11, Vol.12 (11), p.711-723</ispartof><rights>Copyright 2020, Lan et al.</rights><rights>Copyright 2020, Lan et al. 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c257t-3617882830c12ec30a250984f84f6a409114e6afeca78b8755be782a4c9fec383</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665869/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665869/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33224373$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lan, Changgui</creatorcontrib><creatorcontrib>Hu, Liping</creatorcontrib><creatorcontrib>Liao, Chengqi</creatorcontrib><creatorcontrib>Shi, Yuhong</creatorcontrib><creatorcontrib>Wang, Yi</creatorcontrib><creatorcontrib>Cheng, Shuanghua</creatorcontrib><creatorcontrib>Huang, Wei</creatorcontrib><title>Thyroid-Stimulating Hormone Receptor Autoimmunity and Local Factors in Multiple Risk Factors Are Mainly Involved in the Occurrence of Pretibial Myxedema</title><title>Journal of clinical medicine research</title><addtitle>J Clin Med Res</addtitle><description>Pretibial myxedema (PTM) is a local mucinous dermopathy associated with thyroid diseases. Since the etiology of PTM is unclear, the aim of this study is to identify the risk factors for PTM and their etiological roles in PTM occurrence. A large-scale case-control study (n = 1,200) was performed to identify risk factors for PTM by calculating odds ratio (OR) values and 95% confidential intervals. The PTM group entered a glucocorticoid treatment trial. Patients with complete response were followed up to the first relapse in a cohort study. The relative risk (RR) values of the main risk factors were calculated for PTM relapse to test their etiological roles. Among the 19 factors, six risk factors were identified: thyroid-stimulating hormone (TSH) receptor antibody (TRAb) (OR 42.93), autoimmune thyroid disease (AITD) or AITD history (OR 10.30), local trauma (OR 6.55), venous stasis posture (OR 6.16), cigarette smoking (OR 4.48), and age (OR 1.05). Serum TRAb levels were positively correlated with the severity of PTM. Of note, 371/400 patients received glucocorticoid treatment, and 330 achieved complete response. The serum TRAb levels after treatment decreased dramatically compared with those before treatment. After stopping glucocorticoid treatment, serum TRAb levels increased significantly when PTM relapsed (P &lt; 0.001). In 165 relapse cases, an increase in serum TRAb levels occurred first, followed by persistent venous stasis posture or local trauma and finally PTM. The RR of elevated serum TRAb levels was 6.73 in PTM relapse cases. In the elevated serum TRAb level group, the RRs of local trauma, venous stasis posture, and local trauma plus venous stasis posture were 8.81, 6.5, and 8.84, respectively, for PTM relapse cases. TSHR autoimmunity and local factors in the six identified risk factors are the main causes of PTM occurrence.</description><subject>Original</subject><issn>1918-3003</issn><issn>1918-3011</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVkd9qFDEUxoMotrS98QEklyKM5t_MZG6EpVhb2KXS1uuQzZzppmaSNckszpv4uEZbh3oInEO-3_kS-BB6Q8kHKlpBPj4EM0bBa_YCHdOOyooTSl8uM-FH6CylB1KKcyqJfI2OOGdM8JYfo193uzkG21e32Y6T09n6e3wZ4hg84BswsM8h4tWUgx3Hyds8Y-17vA5GO3yhTVETth5vJpft3pUdm74vwioC3mjr3Yyv_CG4A_R_4LwDfG3MFCN4AzgM-GuEbLe2eG7mn9DDqE_Rq0G7BGdP_QR9u_h8d35Zra-_XJ2v1pVhdZsr3tBWSiY5MZSB4USzmnRSDOU0WpCOUgGNHsDoVm5lW9dbaCXTwnTljkt-gj49-u6n7Qi9AZ-jdmof7ajjrIK26n_F2526DwfVNk0tm64YvHsyiOHHBCmr0SYDzmkPYUqKiYY3hHUdLej7R9TEkFKEYXmGEvU3TbWkWeC3zz-2oP-y478BWiOelA</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Lan, Changgui</creator><creator>Hu, Liping</creator><creator>Liao, Chengqi</creator><creator>Shi, Yuhong</creator><creator>Wang, Yi</creator><creator>Cheng, Shuanghua</creator><creator>Huang, Wei</creator><general>Elmer Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201101</creationdate><title>Thyroid-Stimulating Hormone Receptor Autoimmunity and Local Factors in Multiple Risk Factors Are Mainly Involved in the Occurrence of Pretibial Myxedema</title><author>Lan, Changgui ; Hu, Liping ; Liao, Chengqi ; Shi, Yuhong ; Wang, Yi ; Cheng, Shuanghua ; Huang, Wei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c257t-3617882830c12ec30a250984f84f6a409114e6afeca78b8755be782a4c9fec383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Original</topic><toplevel>online_resources</toplevel><creatorcontrib>Lan, Changgui</creatorcontrib><creatorcontrib>Hu, Liping</creatorcontrib><creatorcontrib>Liao, Chengqi</creatorcontrib><creatorcontrib>Shi, Yuhong</creatorcontrib><creatorcontrib>Wang, Yi</creatorcontrib><creatorcontrib>Cheng, Shuanghua</creatorcontrib><creatorcontrib>Huang, Wei</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lan, Changgui</au><au>Hu, Liping</au><au>Liao, Chengqi</au><au>Shi, Yuhong</au><au>Wang, Yi</au><au>Cheng, Shuanghua</au><au>Huang, Wei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thyroid-Stimulating Hormone Receptor Autoimmunity and Local Factors in Multiple Risk Factors Are Mainly Involved in the Occurrence of Pretibial Myxedema</atitle><jtitle>Journal of clinical medicine research</jtitle><addtitle>J Clin Med Res</addtitle><date>2020-11-01</date><risdate>2020</risdate><volume>12</volume><issue>11</issue><spage>711</spage><epage>723</epage><pages>711-723</pages><issn>1918-3003</issn><eissn>1918-3011</eissn><abstract>Pretibial myxedema (PTM) is a local mucinous dermopathy associated with thyroid diseases. Since the etiology of PTM is unclear, the aim of this study is to identify the risk factors for PTM and their etiological roles in PTM occurrence. A large-scale case-control study (n = 1,200) was performed to identify risk factors for PTM by calculating odds ratio (OR) values and 95% confidential intervals. The PTM group entered a glucocorticoid treatment trial. Patients with complete response were followed up to the first relapse in a cohort study. The relative risk (RR) values of the main risk factors were calculated for PTM relapse to test their etiological roles. Among the 19 factors, six risk factors were identified: thyroid-stimulating hormone (TSH) receptor antibody (TRAb) (OR 42.93), autoimmune thyroid disease (AITD) or AITD history (OR 10.30), local trauma (OR 6.55), venous stasis posture (OR 6.16), cigarette smoking (OR 4.48), and age (OR 1.05). Serum TRAb levels were positively correlated with the severity of PTM. Of note, 371/400 patients received glucocorticoid treatment, and 330 achieved complete response. The serum TRAb levels after treatment decreased dramatically compared with those before treatment. After stopping glucocorticoid treatment, serum TRAb levels increased significantly when PTM relapsed (P &lt; 0.001). In 165 relapse cases, an increase in serum TRAb levels occurred first, followed by persistent venous stasis posture or local trauma and finally PTM. The RR of elevated serum TRAb levels was 6.73 in PTM relapse cases. In the elevated serum TRAb level group, the RRs of local trauma, venous stasis posture, and local trauma plus venous stasis posture were 8.81, 6.5, and 8.84, respectively, for PTM relapse cases. TSHR autoimmunity and local factors in the six identified risk factors are the main causes of PTM occurrence.</abstract><cop>Canada</cop><pub>Elmer Press</pub><pmid>33224373</pmid><doi>10.14740/jocmr4352</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1918-3003
ispartof Journal of clinical medicine research, 2020-11, Vol.12 (11), p.711-723
issn 1918-3003
1918-3011
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7665869
source PubMed Central
subjects Original
title Thyroid-Stimulating Hormone Receptor Autoimmunity and Local Factors in Multiple Risk Factors Are Mainly Involved in the Occurrence of Pretibial Myxedema
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T01%3A57%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thyroid-Stimulating%20Hormone%20Receptor%20Autoimmunity%20and%20Local%20Factors%20in%20Multiple%20Risk%20Factors%20Are%20Mainly%20Involved%20in%20the%20Occurrence%20of%20Pretibial%20Myxedema&rft.jtitle=Journal%20of%20clinical%20medicine%20research&rft.au=Lan,%20Changgui&rft.date=2020-11-01&rft.volume=12&rft.issue=11&rft.spage=711&rft.epage=723&rft.pages=711-723&rft.issn=1918-3003&rft.eissn=1918-3011&rft_id=info:doi/10.14740/jocmr4352&rft_dat=%3Cproquest_pubme%3E2463602991%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c257t-3617882830c12ec30a250984f84f6a409114e6afeca78b8755be782a4c9fec383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2463602991&rft_id=info:pmid/33224373&rfr_iscdi=true